SI3287133T1 - Polimeri, ki vežejo protone,za peroralno dajanje - Google Patents

Polimeri, ki vežejo protone,za peroralno dajanje

Info

Publication number
SI3287133T1
SI3287133T1 SI201431241T SI201431241T SI3287133T1 SI 3287133 T1 SI3287133 T1 SI 3287133T1 SI 201431241 T SI201431241 T SI 201431241T SI 201431241 T SI201431241 T SI 201431241T SI 3287133 T1 SI3287133 T1 SI 3287133T1
Authority
SI
Slovenia
Prior art keywords
proton
oral administration
binding polymers
polymers
binding
Prior art date
Application number
SI201431241T
Other languages
English (en)
Slovenian (sl)
Inventor
Gerrit Klaerner
Eric F. Connor
Randi K. Gbur
Matthew J. Kade
Paul H. Kierstead
Jerry M. Buysse
Michael J. Cope
Kalpesh N. Biyani
Son H. Nguyen
Scott M. Tabakman
Original Assignee
Tricida Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tricida Inc. filed Critical Tricida Inc.
Publication of SI3287133T1 publication Critical patent/SI3287133T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F226/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
    • C08F226/02—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen by a single or double bond to nitrogen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/024—Polyamines containing oxygen in the form of ether bonds in the main chain
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
    • G01N2001/4083—Concentrating samples by other techniques involving separation of suspended solids sedimentation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
    • G01N2001/4088—Concentrating samples by other techniques involving separation of suspended solids filtration
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
SI201431241T 2013-06-05 2014-06-05 Polimeri, ki vežejo protone,za peroralno dajanje SI3287133T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361831445P 2013-06-05 2013-06-05
EP17177221.3A EP3287133B1 (en) 2013-06-05 2014-06-05 Proton-binding polymers for oral administration

Publications (1)

Publication Number Publication Date
SI3287133T1 true SI3287133T1 (sl) 2019-09-30

Family

ID=51212941

Family Applications (3)

Application Number Title Priority Date Filing Date
SI201431241T SI3287133T1 (sl) 2013-06-05 2014-06-05 Polimeri, ki vežejo protone,za peroralno dajanje
SI201430466T SI3003327T1 (en) 2013-06-05 2014-06-05 Polymers that bind protons for oral administration
SI201431698T SI3578185T1 (sl) 2013-06-05 2014-06-05 Polimeri, ki vežejo protone za oralno administracijo

Family Applications After (2)

Application Number Title Priority Date Filing Date
SI201430466T SI3003327T1 (en) 2013-06-05 2014-06-05 Polymers that bind protons for oral administration
SI201431698T SI3578185T1 (sl) 2013-06-05 2014-06-05 Polimeri, ki vežejo protone za oralno administracijo

Country Status (26)

Country Link
US (8) US9205107B2 (enExample)
EP (4) EP3578185B1 (enExample)
JP (5) JP6453860B2 (enExample)
KR (5) KR102633597B1 (enExample)
CN (3) CN111671767B (enExample)
AU (3) AU2014274817B2 (enExample)
BR (1) BR112015030142B1 (enExample)
CA (1) CA2912911C (enExample)
CY (3) CY1119611T1 (enExample)
DK (3) DK3003327T3 (enExample)
ES (3) ES2834485T3 (enExample)
HK (1) HK1251151B (enExample)
HR (3) HRP20171590T1 (enExample)
HU (3) HUE051198T2 (enExample)
IL (3) IL242758B (enExample)
LT (3) LT3287133T (enExample)
MX (3) MX364785B (enExample)
NO (1) NO2905572T3 (enExample)
PL (2) PL3003327T3 (enExample)
PT (3) PT3578185T (enExample)
RS (2) RS61005B1 (enExample)
RU (1) RU2728778C2 (enExample)
SI (3) SI3287133T1 (enExample)
SM (2) SMT202000596T1 (enExample)
TR (1) TR201909355T4 (enExample)
WO (1) WO2014197725A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102633597B1 (ko) 2013-06-05 2024-02-06 트리시다, 인크. 경구 투여를 위한 양성자-결합 중합체
KR20240008418A (ko) * 2014-12-10 2024-01-18 트리시다, 인크. 경구 투여용 양성자-결합 폴리머
AU2017261337A1 (en) 2016-05-06 2018-11-15 Tricida, Inc. Compositions for and method of treating acid-base disorders
BR112019013364A2 (pt) 2016-12-28 2020-04-14 Fujifilm Corp emulsão de polímero contendo átomo de nitrogênio ou sal do mesmo, método de produção para o mesmo e método de produção para partículas
US10934380B1 (en) 2017-09-25 2021-03-02 Tricida, Inc. Crosslinked poly(allylamine) polymer pharmaceutical compositions
TW201922267A (zh) 2017-10-16 2019-06-16 日商富士軟片股份有限公司 高磷血症治療劑
US11266684B2 (en) 2017-11-03 2022-03-08 Tricida, Inc. Compositions for and method of treating acid-base disorders
AU2018360868B2 (en) * 2017-11-03 2025-01-02 Tricida, Inc. Method of treating acid-base disorders
EP3740201A4 (en) * 2018-06-04 2021-03-17 Tricida Inc. METHOD FOR TREATMENT OF ACID-BASE DISORDER
JP2022540707A (ja) * 2019-07-19 2022-09-16 アカテコール・インコーポレイテッド 分子的に十分に規定された生物付着防止ポリイオンコーティング
DK4053179T3 (da) 2021-03-01 2025-11-17 Renosis Inc Farmaceutiske sammensætninger med krydsbundne poly(allylamin)-polymer
MX2023010252A (es) 2021-03-01 2024-02-27 Renosis Inc Composiciones farmaceuticas de polimero de poli(alilamina) reticulado.
WO2023109825A1 (zh) * 2021-12-14 2023-06-22 上海石趣医药科技有限公司 氧化银和/或其水合物在制备药物中的用途
CN115260355A (zh) * 2022-05-16 2022-11-01 江苏中天药业有限公司 一种阴离子交换树脂、其制备方法、该树脂与药物的复合物和其掩味制剂
KR20240128205A (ko) 2023-02-17 2024-08-26 주식회사 쓰리디코리아 손잡이가 있는 운동기구용 개인별 맞춤형 그립 제조방법 및 그로써 제조된 개인별 맞춤형 그립
CN117164854A (zh) * 2023-07-07 2023-12-05 中国科学院长春应用化学研究所 一种交联型聚酰亚胺及其制备方法

Family Cites Families (125)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6444221B1 (en) 1992-06-30 2002-09-03 Howard K. Shapiro Methods of treating chronic inflammatory diseases using carbonyl trapping agents
US20050090553A1 (en) 1992-06-30 2005-04-28 Shapiro Howard K. Compositions and method for treatment of chronic inflammatory diseases
CA2202397C (en) 1994-10-17 2002-07-16 Peter W. Stacpoole Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and methods for treatment of metabolic and cardiovascular disorders
US5534259A (en) * 1993-07-08 1996-07-09 Liposome Technology, Inc. Polymer compound and coated particle composition
US5496545A (en) 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5667775A (en) 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5648355A (en) 1994-02-09 1997-07-15 Kos Pharmaceutical, Inc. Method of treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin
TW474813B (en) 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient
US20020006899A1 (en) 1998-10-06 2002-01-17 Pospisilik Andrew J. Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals
US5753706A (en) 1996-12-16 1998-05-19 Hsu; Chen Hsing Methods for treating renal failure
AUPO758297A0 (en) 1997-06-27 1997-07-24 Rowe, James Baber Control of acidic gut syndrome
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
EP1044021B1 (en) * 1998-01-05 2009-09-23 The University of Washington Enhanced transport using membrane disruptive agents
WO1999040990A1 (en) 1998-02-17 1999-08-19 University Of Maryland Anion binding polymers and the use thereof
US6485703B1 (en) 1998-07-31 2002-11-26 The Texas A&M University System Compositions and methods for analyte detection
US6271264B1 (en) 1998-12-01 2001-08-07 Geltex Pharmaceuticals, Inc. Polymers containing spirobicyclic ammonium moieties as bile acid sequestrants
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
GB9927088D0 (en) 1999-11-17 2000-01-12 Secr Defence Use of poly(diallylamine) polymers
US20040059065A1 (en) 2000-03-09 2004-03-25 Takeshi Goto Crosslinked anion-exchange resin or salt thereof
AU2001241077A1 (en) 2000-03-09 2001-09-17 Hisamitsu Pharmaceutical Co. Inc. Crosslinked anion-exchange resin or salt thereof and phosphorus adsorbent comprising the same
AU2001241095A1 (en) 2000-03-13 2001-09-24 Hisamitsu Pharmaceutical Co. Inc. Preventives and/or remedies for hyperphosphatemia
JP2002028737A (ja) 2000-07-07 2002-01-29 Fujitsu Ltd プレス打ち抜き加工方法及びプレス打ち抜き加工装置
BR0209133A (pt) 2001-04-18 2004-06-15 Genzyme Corp Método para tratar gota e para reduzir os nìveis de ácido úrico n0 sangue
KR20040018357A (ko) * 2001-04-18 2004-03-03 젠자임 코포레이션 저염 형태의 폴리알릴아민
BR0308316A (pt) 2002-03-11 2004-12-28 Novartis Ag Sais de nateglinida
JP2007523599A (ja) 2003-02-10 2007-08-23 オートゲン リサーチ ピーティーワイ エルティーディー． 治療用分子
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
CN1540136A (zh) * 2003-10-27 2004-10-27 华东理工大学 一种评价微生物驱油能力的方法
US7459502B2 (en) 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7608674B2 (en) * 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
WO2006043984A2 (en) * 2004-10-13 2006-04-27 Ilypsa, Inc. Crosslinked amine polymers
US7449605B2 (en) 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7767768B2 (en) 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7385012B2 (en) 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
AU2004311849B2 (en) 2003-12-31 2009-04-02 Genzyme Corporation Enteric coated aliphatic amine polymer bile acid sequestrants
AU2004314652A1 (en) 2004-01-29 2005-08-11 Keio University Erythrocyte function modifying substance
US7429394B2 (en) 2004-03-30 2008-09-30 Relypsa, Inc. Ion binding compositions
US7854924B2 (en) 2004-03-30 2010-12-21 Relypsa, Inc. Methods and compositions for treatment of ion imbalances
US8192758B2 (en) 2004-03-30 2012-06-05 Relypsa, Inc. Ion binding compositions
US8282960B2 (en) 2004-03-30 2012-10-09 Relypsa, Inc. Ion binding compositions
EP1732523B9 (en) 2004-03-30 2010-06-02 Relypsa, Inc. Potassium binding polymers and uses thereof
US7556799B2 (en) 2004-03-30 2009-07-07 Relypsa, Inc. Ion binding polymers and uses thereof
US8399025B2 (en) 2004-06-04 2013-03-19 Board Of Regents, The University Of Texas System Polyamine modified particles
EP2705849B1 (en) 2004-07-19 2018-04-04 N.V. Nutricia A preparation for use of aspartate for regulating glucose levels in blood
DE102004035808A1 (de) 2004-07-21 2006-03-16 Kasch, Helmut, Dr. Ammoniumsalze und Ammoniumsalz-Mineralsalzchlatrate als Transport- und Wirkform für pharmazeutische-medizinische und als Phasentransfermittel für chemische Anwendungen
US8569277B2 (en) 2004-08-11 2013-10-29 Palo Alto Investors Methods of treating a subject for a condition
US20070293429A1 (en) 2004-10-08 2007-12-20 Therapei Pharmaceuticals, Inc. Vasoactive Intestinal Polypeptide Compositions
US20080214440A1 (en) 2004-10-08 2008-09-04 Forbes Medi-Tech (Research), Inc. Vasoactive intestinal polypeptide compositions
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
ITME20040015A1 (it) 2004-12-07 2005-03-07 Vincenzo Savica Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.
WO2006078629A2 (en) * 2005-01-18 2006-07-27 Duke University In-situ crosslinkable elastin-like polypeptides for defect filling in cartilaginous tissue repair
CA2613875C (en) 2005-07-04 2018-09-25 Ramu Krishnan Improved drug or pharmaceutical compounds and a preparation thereof
HUE025264T2 (en) 2005-08-18 2016-02-29 Panion & Bf Biotech Inc Pharmaceutical-grade ferric citrate for medical use
EP1951266A2 (en) 2005-09-02 2008-08-06 Genzyme Corporation Method for removing phosphate and polymer used therefore
US8586097B2 (en) 2005-09-30 2013-11-19 Relypsa, Inc. Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom
WO2007038801A2 (en) 2005-09-30 2007-04-05 Ilypsa, Inc. Monovalent cation-binding compositions comprising core-shell particles having crosslinked poly-vinylic shells, and methods of use thereof
KR20080059265A (ko) * 2005-09-30 2008-06-26 일립사, 인코포레이티드 포유동물의 위장관으로부터 칼륨 이온을 선택적으로제거하기 위한 방법 및 조성물
US20090162314A1 (en) 2005-11-08 2009-06-25 Huval Chad C Magnesium-Containing Polymers for the Treatment of Hyperphosphatemia
CN102600202A (zh) 2005-11-08 2012-07-25 味之素株式会社 麻醉苏醒促进剂
ITMI20052461A1 (it) 2005-12-22 2007-06-23 Univ Degli Studi Milano Sistemi microparticellari per la somministrazione orale di sostanze biologicamente attive
RU2008136081A (ru) 2006-02-14 2010-03-20 Тева Фармасьютикл Индастриес Лтд. (Il) Фармацевтические составы с алифатическими аминными полимерами и способы их производства
JP2009536246A (ja) 2006-05-05 2009-10-08 ゲンズイメ コーポレーション ホスフェート捕捉剤としてのアミン縮合重合体
JP2009542653A (ja) 2006-07-05 2009-12-03 ジェンザイム コーポレーション リン酸塩過剰血症のための鉄（ｉｉ）含有治療剤
MX2009000611A (es) 2006-07-18 2009-04-16 Genzyme Corp Dendrimeros de amina.
CN101541235A (zh) * 2006-07-18 2009-09-23 基酶有限公司 胺类树状物
US8391873B2 (en) 2006-07-21 2013-03-05 Qualcomm Incorporated Systems and methods for coordinating supplementary services for voice telephone calls in a centralized fashion
EP2046284A1 (en) 2006-08-04 2009-04-15 Nastech Pharmaceutical Company Inc. Compositions for intranasal delivery of human insulin and uses thereof
CA2661987C (en) 2006-09-01 2012-11-06 Usv Limited Process for the preparation of sevelamer hydrochloride and formulation thereof
US7964182B2 (en) * 2006-09-01 2011-06-21 USV, Ltd Pharmaceutical compositions comprising phosphate-binding polymer
WO2008027551A2 (en) * 2006-09-01 2008-03-06 Genzyme Corporation Dendrimer compositions
EP2059247A1 (en) 2006-09-06 2009-05-20 Sucampo AG Method and composition for promoting gastrointestinal bicarbonate secretion
EP2066293A2 (en) 2006-09-29 2009-06-10 Genzyme Corporation Amide dendrimer compositions
WO2008076242A1 (en) 2006-12-14 2008-06-26 Genzyme Corporation Amido-amine polymer compositions
JP2010519298A (ja) 2007-02-23 2010-06-03 ゲンズイメ コーポレーション アミンポリマー組成物
US20080207766A1 (en) 2007-02-27 2008-08-28 Agi Therapeutics Research Ltd. Methods and compositions for treating at least one upper gastrointestinal symptom
EP2131820A1 (en) 2007-03-08 2009-12-16 Genzyme Corporation Sulfone polymer compositions
TWI445540B (zh) 2007-04-20 2014-07-21 Ajinomoto Kk 抗低體溫組成物
WO2008133954A1 (en) 2007-04-27 2008-11-06 Genzyme Corporation Amido-amine dendrimer compositions
US8273384B2 (en) 2007-07-02 2012-09-25 Stephen Ray Wurzberger Process for the preparation of a non-corrosive base solution and methods of using same
KR20100045965A (ko) * 2007-07-11 2010-05-04 도레이 카부시키가이샤 가교 폴리알릴아민 또는 그 산부가염 및 그 의약 용도
EP2016947A1 (en) 2007-07-17 2009-01-21 Chemo Ibérica, S.A. Novel one step process for preparing cross-linked poly(allylamine) polymers
WO2009023544A2 (en) 2007-08-10 2009-02-19 Ilypsa, Inc. Dosage unit anion-exchange polymer pharmaceutical compositions
US20090181359A1 (en) * 2007-10-25 2009-07-16 Lou Sheng C Method of performing ultra-sensitive immunoassays
US20090156647A1 (en) 2007-12-12 2009-06-18 Iovate T. & P. Inc. Method for maintaining physiological pH levels during intensive physical exercise
EP2217215A1 (en) 2007-12-14 2010-08-18 Genzyme Corporation Coated pharmaceutical compositions
PA8807201A1 (es) 2007-12-14 2009-07-23 Genzyme Corp Composiciones farmaceuticas
WO2009097127A1 (en) 2008-01-31 2009-08-06 Genzyme Corporation Pharmaceutical compositions
US20100035992A1 (en) 2008-03-11 2010-02-11 Rajiv Bhushan Methods and Compositions for Treating Inflammation and Inflammation-Related Pathologies
RU2010145166A (ru) 2008-04-08 2012-05-20 Юсв Лимитед (In) Способ получения соли аминополимера
CN102014843B (zh) 2008-04-11 2013-06-19 Gp合资有限公司 用于人体组织的超声处理的机头
US20110142952A1 (en) 2008-06-20 2011-06-16 Harris David J Pharmaceutical Compositions
DE102008030046A1 (de) 2008-06-25 2009-12-31 Ratiopharm Gmbh Kompaktiertes Polyallylamin-Polymer
US20100008988A1 (en) 2008-07-14 2010-01-14 Glenmark Generics, Ltd. Tablet compositions of amine polymers
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
US8337824B2 (en) 2008-08-22 2012-12-25 Relypsa, Inc. Linear polyol stabilized polyfluoroacrylate compositions
WO2010022381A1 (en) 2008-08-22 2010-02-25 Relypsa, Inc. Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties
CA2737452C (en) 2008-09-25 2018-05-22 Vive Nano Inc. Methods to produce polymer nanoparticles and formulations of active ingredients
US20110268666A1 (en) 2008-09-29 2011-11-03 Yissum Research Development Company of the Research University of Jerusalem, Ltd. Novel gastroretentive delivery system
US20100113479A1 (en) 2008-10-30 2010-05-06 Anusuya Choudhury Process for the preparation of tri-substituted pyridine and tri-substituted pyrimidine derivatives useful as gdir agonists
US20100166861A1 (en) 2008-12-29 2010-07-01 Kelly Noel Lynch Pharmaceutical formulations of sevalamer, or salts thereof, and copovidone
CA2749397A1 (en) 2009-01-22 2010-08-05 Usv Limited Pharmaceutical compositions comprising phosphate-binding polymer
WO2011059609A2 (en) 2009-10-13 2011-05-19 The Regents Of The University Of Michigan Dendrimer compositions and methods of synthesis
WO2011047700A1 (en) 2009-10-22 2011-04-28 Synthon B.V. Pharmaceutical compositions of sevelamer
WO2011071927A2 (en) 2009-12-07 2011-06-16 Ironwood Pharmaceuticals, Inc. Treatments for gastrointestinal disorders
JP5865847B2 (ja) * 2010-02-24 2016-02-17 レリプサ， インコーポレイテッド 胆汁酸捕捉剤として使用するための架橋されたポリビニルアミン、ポリアリルアミンおよびポリエチレンイミン
BR112012021448A2 (pt) 2010-02-24 2016-05-31 Relypsa Inc polímero de amina, método para tratar doença, método de remoção de sais biliares de um indivíduo animal, método para melhorar o controle glicêmico em um indivíduo, e, processo para preparar o polímero de amina.
EP2539389B1 (en) * 2010-02-24 2017-12-20 Relypsa, Inc. Amine polymers for use as bile acid sequestrants
RU2417782C1 (ru) * 2010-03-03 2011-05-10 Федеральное государственное образовательное учреждение высшего профессионального образования "Белгородская государственная сельскохозяйственная академия" Способ лечения ацидоза рубца
IT1406068B1 (it) 2010-07-22 2014-02-06 Medestea Int Spa Polidesossiribonucleotidi (pdrn) per l'impiego nel trattamento di condizioni di acidosi e composizioni a base di polidesossiribonucleotidi per il suddetto impiego
US20140072983A1 (en) * 2010-08-10 2014-03-13 Amgen Inc. Dual function in vitro target binding assay for the detection of neutralizing antibodies against target antibodies
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
KR101238210B1 (ko) 2011-06-30 2013-03-04 엘지전자 주식회사 이동 단말기
US20130137772A1 (en) 2011-11-29 2013-05-30 Raymond J. Bergeron Hydroxypolyamine salts
SG11201408521WA (en) 2012-06-21 2015-01-29 Keryx Biopharmaceuticals Inc Use of ferric citrate in the treatment of chronic kidney disease patients
EP2916851B1 (en) 2012-10-08 2025-12-17 Vifor (International) Ltd. Potassium-binding agents for treating hypertension and hyperkalemia
KR102633597B1 (ko) * 2013-06-05 2024-02-06 트리시다, 인크. 경구 투여를 위한 양성자-결합 중합체
CN105873583A (zh) 2013-11-04 2016-08-17 凯克斯生物制药公司 用于降低慢性肾病患者的心力衰竭的枸橼酸铁
KR20240008418A (ko) 2014-12-10 2024-01-18 트리시다, 인크. 경구 투여용 양성자-결합 폴리머
AU2017261337A1 (en) 2016-05-06 2018-11-15 Tricida, Inc. Compositions for and method of treating acid-base disorders
AU2018360868B2 (en) 2017-11-03 2025-01-02 Tricida, Inc. Method of treating acid-base disorders
US11266684B2 (en) 2017-11-03 2022-03-08 Tricida, Inc. Compositions for and method of treating acid-base disorders
EP3740201A4 (en) 2018-06-04 2021-03-17 Tricida Inc. METHOD FOR TREATMENT OF ACID-BASE DISORDER
WO2019236124A1 (en) 2018-06-04 2019-12-12 Tricida, Inc. Method of treating acid-base disorders
WO2019236639A1 (en) 2018-06-04 2019-12-12 Tricida, Inc. Method of treating acid-base disorders

Also Published As

Publication number Publication date
JP6453860B2 (ja) 2019-01-16
MX2019005300A (es) 2019-08-12
LT3578185T (lt) 2020-11-25
KR20210131457A (ko) 2021-11-02
DK3287133T3 (da) 2019-07-01
EP3578185A1 (en) 2019-12-11
ES2646271T3 (es) 2017-12-13
CN105377270B (zh) 2020-09-04
MX387845B (es) 2025-03-19
US20220096534A1 (en) 2022-03-31
PT3578185T (pt) 2020-11-10
CN105377270A (zh) 2016-03-02
KR102717667B1 (ko) 2024-10-16
CA2912911C (en) 2023-10-03
KR20240023672A (ko) 2024-02-22
HK1222120A1 (zh) 2017-06-23
MX2021013880A (es) 2022-06-02
PL3003327T3 (pl) 2018-02-28
HRP20171590T1 (hr) 2017-12-29
US20180280428A1 (en) 2018-10-04
US20190134075A1 (en) 2019-05-09
KR20240152425A (ko) 2024-10-21
CA2912911A1 (en) 2014-12-11
CN111671767A (zh) 2020-09-18
JP6759316B2 (ja) 2020-09-23
DK3003327T3 (en) 2017-10-23
JP2022107004A (ja) 2022-07-20
CY1121801T1 (el) 2020-07-31
HUE034836T2 (en) 2018-03-28
MX2015016527A (es) 2016-07-22
HK1223288A1 (en) 2017-07-28
US20190231812A1 (en) 2019-08-01
US20160074430A1 (en) 2016-03-17
SMT202000596T1 (it) 2021-01-05
CY1119611T1 (el) 2018-04-04
RS59033B1 (sr) 2019-08-30
MX364785B (es) 2019-05-07
PT3287133T (pt) 2019-07-12
SI3003327T1 (en) 2018-01-31
RU2015155596A (ru) 2017-07-18
AU2019275584B2 (en) 2021-10-21
CY1123673T1 (el) 2022-03-24
IL278183B (en) 2021-09-30
JP2020203917A (ja) 2020-12-24
JP2025024009A (ja) 2025-02-19
US10369169B1 (en) 2019-08-06
US10391118B2 (en) 2019-08-27
BR112015030142A2 (pt) 2017-07-25
LT3003327T (lt) 2017-12-27
US9993500B2 (en) 2018-06-12
KR102633597B1 (ko) 2024-02-06
CN111671766B (zh) 2024-03-08
HK1251151B (en) 2020-04-24
AU2019275584A1 (en) 2020-01-02
EP3003327B1 (en) 2017-08-09
EP3812761B1 (en) 2025-12-24
IL271932B (en) 2020-11-30
SI3578185T1 (sl) 2021-01-29
LT3287133T (lt) 2019-07-10
BR112015030142B1 (pt) 2023-03-07
AU2014274817A1 (en) 2015-12-24
PL3287133T3 (pl) 2019-10-31
NO2905572T3 (enExample) 2017-12-16
ES2834485T3 (es) 2021-06-17
IL271932A (en) 2020-02-27
US10363268B2 (en) 2019-07-30
EP3578185B1 (en) 2020-08-05
US20150056451A1 (en) 2015-02-26
EP3812761A1 (en) 2021-04-28
US20180015121A1 (en) 2018-01-18
EP3003327A1 (en) 2016-04-13
CN111671767B (zh) 2024-03-08
HUE051198T2 (hu) 2021-03-01
RS61005B1 (sr) 2020-11-30
JP7075455B2 (ja) 2022-05-25
EP3287133B1 (en) 2019-04-17
HRP20191074T1 (hr) 2019-09-20
IL242758B (en) 2020-01-30
AU2014274817B2 (en) 2019-05-23
WO2014197725A1 (en) 2014-12-11
US20200206260A1 (en) 2020-07-02
EP3287133A1 (en) 2018-02-28
SMT201900391T1 (it) 2019-09-09
IL278183A (en) 2020-11-30
HRP20201767T1 (hr) 2020-12-25
RU2015155596A3 (enExample) 2018-05-10
TR201909355T4 (tr) 2019-07-22
HUE043999T2 (hu) 2019-09-30
KR102318910B1 (ko) 2021-10-29
DK3578185T3 (da) 2020-11-02
CN111671766A (zh) 2020-09-18
PT3003327T (pt) 2017-11-09
RU2728778C2 (ru) 2020-07-31
JP2016520652A (ja) 2016-07-14
JP7588871B2 (ja) 2024-11-25
US11197887B2 (en) 2021-12-14
AU2019219800B1 (en) 2019-09-19
ES2733493T3 (es) 2019-11-29
JP2019065024A (ja) 2019-04-25
US9925214B2 (en) 2018-03-27
KR20160041855A (ko) 2016-04-18
KR20230114326A (ko) 2023-08-01
US9205107B2 (en) 2015-12-08

Similar Documents

Publication Publication Date Title
IL278183A (en) Proton-binding polymers for oral administration
IL290729B2 (en) Proton-binding polymers for oral administration
IL246377A0 (en) Pharmaceutical preparations for oral administration
IL240846A0 (en) drug combination
ZA201600027B (en) Pharmaceutical preparation
GB201305103D0 (en) An oral dosage form
GB2520315B (en) Oral Syringes
ZA201506465B (en) Pharmaceutical preparation
GB201309971D0 (en) Oral medicines syringe
GB201316662D0 (en) Pharmaceutical Combination
GB201320786D0 (en) Medicament